FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Labetalol Hydrochloride Injection
Status: Resolved
»Duration of Shortage: 03/01/2017 - 12/09/2020
»Therapeutic Categories: Cardiovascular

Expand all

Akorn Pharmaceuticals (Revised 12/09/2020)

Company Contact Information:
800-932-5676

Presentation
  • 5mg/mL (100mg/20mL) Multi-Dose vial (NDC 17478-420-20)
  • 5mg/mL (200mg/40mL) Multi-Dose vial (NDC 17478-420-40 )
Note:
  • N/A

Gland Pharma Limited (Revised 12/09/2020)

Company Contact Information:
609-250-7990

Presentation
  • 5mg/mL, 20 mL vial (NDC 72266-102-01)
  • 5 mg/mL, 40 mL vial (NDC 72266-103-01)
Note:
  • N/A

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 12/09/2020)

Company Contact Information:
800-631-2174

Presentation
  • 5 mg/mL, 20 mL multidose vial (NDC 0143-9622-01)
  • 5 mg/mL, 40 mL multidose vial (NDC 0143-9623-01)
Note:
  • N/A

Hospira, Inc. (Revised 12/09/2020)

Company Contact Information:
844-646-4398

Presentation
  • 100 mg/20 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2267-20)
  • 200 mg/40 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2267-54)
  • 20 mg/4 mL (5 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-2339-34)
Note:
  • N/A

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English